215 related articles for article (PubMed ID: 20037963)
1. Effect of refrigeration of the antiemetic Cerenia (maropitant) on pain on injection.
Narishetty ST; Galvan B; Coscarelli E; Aleo M; Fleck T; Humphrey W; McCall RB
Vet Ther; 2009; 10(3):93-102. PubMed ID: 20037963
[TBL] [Abstract][Full Text] [Related]
2. The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe.
de la Puente-Redondo VA; Siedek EM; Benchaoui HA; Tilt N; Rowan TG; Clemence RG
J Small Anim Pract; 2007 Feb; 48(2):93-8. PubMed ID: 17286662
[TBL] [Abstract][Full Text] [Related]
3. The neurokinin-1 antagonist activity of maropitant, an antiemetic drug for dogs, in a gerbil model.
de la Puente-Redondo V; Tingley FD; Schneider RP; Hickman MA
J Vet Pharmacol Ther; 2007 Aug; 30(4):281-7. PubMed ID: 17610400
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs.
de la Puente-Redondo VA; Tilt N; Rowan TG; Clemence RG
Am J Vet Res; 2007 Jan; 68(1):48-56. PubMed ID: 17199418
[TBL] [Abstract][Full Text] [Related]
5. The effect of intravenous maropitant on blood pressure in healthy awake and anesthetized dogs.
Chi TT; Hay Kraus BL
PLoS One; 2020; 15(2):e0229736. PubMed ID: 32108177
[TBL] [Abstract][Full Text] [Related]
6. Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats.
Hickman MA; Cox SR; Mahabir S; Miskell C; Lin J; Bunger A; McCall RB
J Vet Pharmacol Ther; 2008 Jun; 31(3):220-9. PubMed ID: 18471143
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of maropitant citrate dosed orally to dogs at 2 mg/kg and 8 mg/kg once daily for 14 days consecutive days.
Lesman SP; Boucher JF; Grover GS; Cox SR; Bidgood TL
J Vet Pharmacol Ther; 2013 Oct; 36(5):462-70. PubMed ID: 23167698
[TBL] [Abstract][Full Text] [Related]
8. Dilution of maropitant (Cerenia) in lactated Ringer solution prolongs subcutaneous drug absorption and reduces maximum plasma concentration.
Yee DE; Ochigbo G; Menard J; Rosa BV
J Am Vet Med Assoc; 2023 Aug; 261(8):1160-1165. PubMed ID: 36884379
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs.
Ramsey DS; Kincaid K; Watkins JA; Boucher JF; Conder GA; Eagleson JS; Clemence RG
J Vet Pharmacol Ther; 2008 Dec; 31(6):538-43. PubMed ID: 19000277
[TBL] [Abstract][Full Text] [Related]
10. Effect of maropitant, a neurokinin 1 receptor antagonist, on anesthetic requirements during noxious visceral stimulation of the ovary in dogs.
Boscan P; Monnet E; Mama K; Twedt DC; Congdon J; Steffey EP
Am J Vet Res; 2011 Dec; 72(12):1576-9. PubMed ID: 22126683
[TBL] [Abstract][Full Text] [Related]
11. Effect of dosing interval on efficacy of maropitant for prevention of hydromorphone-induced vomiting and signs of nausea in dogs.
Hay Kraus BL
J Am Vet Med Assoc; 2014 Nov; 245(9):1015-20. PubMed ID: 25313812
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs.
Benchaoui HA; Cox SR; Schneider RP; Boucher JF; Clemence RG
J Vet Pharmacol Ther; 2007 Aug; 30(4):336-44. PubMed ID: 17610407
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs.
Conder GA; Sedlacek HS; Boucher JF; Clemence RG
J Vet Pharmacol Ther; 2008 Dec; 31(6):528-32. PubMed ID: 19000275
[TBL] [Abstract][Full Text] [Related]
14. Assessment of pre-operative maropitant citrate use in macaque (Macaca fasicularis & Macaca mulatta) neurosurgical procedures.
Steinbach JR; MacGuire J; Chang S; Dierks E; Roble GS
J Med Primatol; 2018 Jun; 47(3):178-184. PubMed ID: 29611200
[TBL] [Abstract][Full Text] [Related]
15. Effects of maropitant citrate or acepromazine on the incidence of adverse events associated with hydromorphone premedication in dogs.
Claude AK; Dedeaux A; Chiavaccini L; Hinz S
J Vet Intern Med; 2014; 28(5):1414-7. PubMed ID: 25146756
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of orally administered maropitant citrate in preventing vomiting associated with hydromorphone administration in dogs.
Hay Kraus BL
J Am Vet Med Assoc; 2014 May; 244(10):1164-9. PubMed ID: 24786163
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pain response after subcutaneous injection of two maropitant formulations to beagle dogs.
Deckers N; Ruigrok CA; Verhoeve HP; Lourens N
Vet Rec Open; 2018; 5(1):e000262. PubMed ID: 29531751
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of injectable maropitant (Cerenia) in a randomized clinical trial for prevention and treatment of cisplatin-induced emesis in dogs presented as veterinary patients.
Vail DM; Rodabaugh HS; Conder GA; Boucher JF; Mathur S
Vet Comp Oncol; 2007 Mar; 5(1):38-46. PubMed ID: 19754800
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal toxicity after vincristine or cyclophosphamide administered with or without maropitant in dogs: a prospective randomised controlled study.
Mason SL; Grant IA; Elliott J; Cripps P; Blackwood L
J Small Anim Pract; 2014 Aug; 55(8):391-8. PubMed ID: 24920169
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the antiemetic efficacy of maropitant in dogs medicated with morphine and acepromazine.
Lorenzutti AM; MartÃn-Flores M; Litterio NJ; Himelfarb MA; Zarazaga MP
Vet Anaesth Analg; 2016 Mar; 43(2):195-8. PubMed ID: 26095960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
